Selected research
Market Outlook & Growth Opportunities
Global OTC Vitamins and Minerals Dietary Supplement Market Outlook and Growth Opportunities 2026
Market perspective
The global OTC Vitamins and Minerals Dietary Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for OTC Vitamins and Minerals Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for OTC Vitamins and Minerals Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for OTC Vitamins and Minerals Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the OTC Vitamins and Minerals Dietary Supplement market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the OTC Vitamins and Minerals Dietary Supplement market include Sanofi, Johnson and Johnson, Merck and Co, Lonza Group, Pfizer, GlaxoSmithKline, AstraZeneca PLC, Roche Holding AG and Reckitt Benckiser, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global OTC Vitamins and Minerals Dietary Supplement market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of OTC Vitamins and Minerals Dietary Supplement and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents OTC Vitamins and Minerals Dietary Supplement revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global OTC Vitamins and Minerals Dietary Supplement market.
OTC Vitamins and Minerals Dietary Supplement Segment by Company
Sanofi
Johnson and Johnson
Merck and Co
Lonza Group
Pfizer
GlaxoSmithKline
AstraZeneca PLC
Roche Holding AG
Reckitt Benckiser
Otsuka Holdings
Koninklijke DSM N.V.
DuPont
Dil Limited
CSPC Pharmaceutical Group
Bactolac Pharmaceutical
Atrium Innovations
Allergan
Abbott Laboratories
OTC Vitamins and Minerals Dietary Supplement Segment by Type
Tablets
Capsules
Others
OTC Vitamins and Minerals Dietary Supplement Segment by Application
Pharmacies
Online Retailers
Supermarkets
Others
OTC Vitamins and Minerals Dietary Supplement Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global OTC Vitamins and Minerals Dietary Supplement status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the OTC Vitamins and Minerals Dietary Supplement key companies, revenue, market share, and recent developments.
3. To split the OTC Vitamins and Minerals Dietary Supplement breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions OTC Vitamins and Minerals Dietary Supplement market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify OTC Vitamins and Minerals Dietary Supplement significant trends, drivers, influence factors in global and regions.
6. To analyze OTC Vitamins and Minerals Dietary Supplement competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Vitamins and Minerals Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Vitamins and Minerals Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Vitamins and Minerals Dietary Supplement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Vitamins and Minerals Dietary Supplement industry.
Chapter 3: Detailed analysis of OTC Vitamins and Minerals Dietary Supplement company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of OTC Vitamins and Minerals Dietary Supplement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of OTC Vitamins and Minerals Dietary Supplement in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
- Others
Applications
- Pharmacies
- Online Retailers
- Supermarkets
- Others
Companies covered
- Sanofi
- Johnson and Johnson
- Merck and Co
- Lonza Group
- Pfizer
- GlaxoSmithKline
- AstraZeneca PLC
- Roche Holding AG
- Reckitt Benckiser
- Otsuka Holdings
- Koninklijke DSM N.V.
- DuPont
- Dil Limited
- CSPC Pharmaceutical Group
- Bactolac Pharmaceutical
- Atrium Innovations
- Allergan
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global OTC Vitamins and Minerals Dietary Supplement Market Size, 2021 VS 2025 VS 2032
- 1.3 Global OTC Vitamins and Minerals Dietary Supplement Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 OTC Vitamins and Minerals Dietary Supplement Market Dynamics
- 2.1 OTC Vitamins and Minerals Dietary Supplement Industry Trends
- 2.2 OTC Vitamins and Minerals Dietary Supplement Industry Drivers
- 2.3 OTC Vitamins and Minerals Dietary Supplement Industry Opportunities and Challenges
- 2.4 OTC Vitamins and Minerals Dietary Supplement Industry Restraints
3 OTC Vitamins and Minerals Dietary Supplement Market by Company
- 3.1 Global OTC Vitamins and Minerals Dietary Supplement Company Revenue Ranking in 2025
- 3.2 Global OTC Vitamins and Minerals Dietary Supplement Revenue by Company (2021-2026)
- 3.3 Global OTC Vitamins and Minerals Dietary Supplement Company Ranking (2024-2026)
- 3.4 Global OTC Vitamins and Minerals Dietary Supplement Company Manufacturing Base and Headquarters
- 3.5 Global OTC Vitamins and Minerals Dietary Supplement Company Product Type and Application
- 3.6 Global OTC Vitamins and Minerals Dietary Supplement Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global OTC Vitamins and Minerals Dietary Supplement Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 OTC Vitamins and Minerals Dietary Supplement Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 OTC Vitamins and Minerals Dietary Supplement Market by Type
- 4.1 OTC Vitamins and Minerals Dietary Supplement Type Introduction
- 4.1.1 Tablets
- 4.1.2 Capsules
- 4.1.3 Others
- 4.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Type
- 4.2.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Type (2021-2032)
- 4.2.3 Global OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type (2021-2032)
5 OTC Vitamins and Minerals Dietary Supplement Market by Application
- 5.1 OTC Vitamins and Minerals Dietary Supplement Application Introduction
- 5.1.1 Pharmacies
- 5.1.2 Online Retailers
- 5.1.3 Supermarkets
- 5.1.4 Others
- 5.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Application
- 5.2.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Application (2021-2032)
- 5.2.3 Global OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application (2021-2032)
6 OTC Vitamins and Minerals Dietary Supplement Regional Value Analysis
- 6.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Region (2021-2032)
- 6.2.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Region: 2021-2026
- 6.2.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America OTC Vitamins and Minerals Dietary Supplement Sales Value (2021-2032)
- 6.3.2 North America OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe OTC Vitamins and Minerals Dietary Supplement Sales Value (2021-2032)
- 6.4.2 Europe OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific OTC Vitamins and Minerals Dietary Supplement Sales Value (2021-2032)
- 6.5.2 Asia-Pacific OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America OTC Vitamins and Minerals Dietary Supplement Sales Value (2021-2032)
- 6.6.2 South America OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa OTC Vitamins and Minerals Dietary Supplement Sales Value (2021-2032)
- 6.7.2 Middle East & Africa OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Country, 2025 VS 2032
7 OTC Vitamins and Minerals Dietary Supplement Country-level Value Analysis
- 7.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Country (2021-2032)
- 7.2.1 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Country (2021-2026)
- 7.2.2 Global OTC Vitamins and Minerals Dietary Supplement Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.3.2 USA OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.7.2 France OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.14.2 China OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.17.2 India OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt OTC Vitamins and Minerals Dietary Supplement Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt OTC Vitamins and Minerals Dietary Supplement Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Johnson and Johnson
- 8.2.1 Johnson and Johnson Company Information
- 8.2.2 Johnson and Johnson Business Overview
- 8.2.3 Johnson and Johnson OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson and Johnson OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.2.5 Johnson and Johnson Recent Developments
- 8.3 Merck and Co
- 8.3.1 Merck and Co Company Information
- 8.3.2 Merck and Co Business Overview
- 8.3.3 Merck and Co OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck and Co OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.3.5 Merck and Co Recent Developments
- 8.4 Lonza Group
- 8.4.1 Lonza Group Company Information
- 8.4.2 Lonza Group Business Overview
- 8.4.3 Lonza Group OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.4.4 Lonza Group OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.4.5 Lonza Group Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 GlaxoSmithKline
- 8.6.1 GlaxoSmithKline Company Information
- 8.6.2 GlaxoSmithKline Business Overview
- 8.6.3 GlaxoSmithKline OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.6.4 GlaxoSmithKline OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.6.5 GlaxoSmithKline Recent Developments
- 8.7 AstraZeneca PLC
- 8.7.1 AstraZeneca PLC Company Information
- 8.7.2 AstraZeneca PLC Business Overview
- 8.7.3 AstraZeneca PLC OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca PLC OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.7.5 AstraZeneca PLC Recent Developments
- 8.8 Roche Holding AG
- 8.8.1 Roche Holding AG Company Information
- 8.8.2 Roche Holding AG Business Overview
- 8.8.3 Roche Holding AG OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.8.4 Roche Holding AG OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.8.5 Roche Holding AG Recent Developments
- 8.9 Reckitt Benckiser
- 8.9.1 Reckitt Benckiser Company Information
- 8.9.2 Reckitt Benckiser Business Overview
- 8.9.3 Reckitt Benckiser OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.9.4 Reckitt Benckiser OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.9.5 Reckitt Benckiser Recent Developments
- 8.10 Otsuka Holdings
- 8.10.1 Otsuka Holdings Company Information
- 8.10.2 Otsuka Holdings Business Overview
- 8.10.3 Otsuka Holdings OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.10.4 Otsuka Holdings OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.10.5 Otsuka Holdings Recent Developments
- 8.11 Koninklijke DSM N.V.
- 8.11.1 Koninklijke DSM N.V. Company Information
- 8.11.2 Koninklijke DSM N.V. Business Overview
- 8.11.3 Koninklijke DSM N.V. OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.11.4 Koninklijke DSM N.V. OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.11.5 Koninklijke DSM N.V. Recent Developments
- 8.12 DuPont
- 8.12.1 DuPont Company Information
- 8.12.2 DuPont Business Overview
- 8.12.3 DuPont OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.12.4 DuPont OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.12.5 DuPont Recent Developments
- 8.13 Dil Limited
- 8.13.1 Dil Limited Company Information
- 8.13.2 Dil Limited Business Overview
- 8.13.3 Dil Limited OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.13.4 Dil Limited OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.13.5 Dil Limited Recent Developments
- 8.14 CSPC Pharmaceutical Group
- 8.14.1 CSPC Pharmaceutical Group Company Information
- 8.14.2 CSPC Pharmaceutical Group Business Overview
- 8.14.3 CSPC Pharmaceutical Group OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.14.4 CSPC Pharmaceutical Group OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.14.5 CSPC Pharmaceutical Group Recent Developments
- 8.15 Bactolac Pharmaceutical
- 8.15.1 Bactolac Pharmaceutical Company Information
- 8.15.2 Bactolac Pharmaceutical Business Overview
- 8.15.3 Bactolac Pharmaceutical OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.15.4 Bactolac Pharmaceutical OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.15.5 Bactolac Pharmaceutical Recent Developments
- 8.16 Atrium Innovations
- 8.16.1 Atrium Innovations Company Information
- 8.16.2 Atrium Innovations Business Overview
- 8.16.3 Atrium Innovations OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.16.4 Atrium Innovations OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.16.5 Atrium Innovations Recent Developments
- 8.17 Allergan
- 8.17.1 Allergan Company Information
- 8.17.2 Allergan Business Overview
- 8.17.3 Allergan OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.17.4 Allergan OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.17.5 Allergan Recent Developments
- 8.18 Abbott Laboratories
- 8.18.1 Abbott Laboratories Company Information
- 8.18.2 Abbott Laboratories Business Overview
- 8.18.3 Abbott Laboratories OTC Vitamins and Minerals Dietary Supplement Revenue and Gross Margin (2021-2026)
- 8.18.4 Abbott Laboratories OTC Vitamins and Minerals Dietary Supplement Product Portfolio
- 8.18.5 Abbott Laboratories Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst